Close Menu
Home » Newtopia Inks Aetna Contract for Metabolic Syndrome Personalized Med Program

Newtopia Inks Aetna Contract for Metabolic Syndrome Personalized Med Program

Feb 18, 2015
|
staff reporter

NEW YORK (GenomeWeb) – Following a pilot study, Newtopia has signed a contract to provide Aetna's customers with a personalized health program that utilizes genetic testing and behavioral science targeted at those with metabolic syndrome.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Test of Antibodies

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

New York Rats Through and Through

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Powerhouse of the Cell, Lost

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

Science Papers Discuss AI in Drug Discovery, Find Two Red Panda Species

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

What's Popular?

In Business News

  1. MGI Unveils 'Extreme Throughput' Sequencing Platform at AGBT to Enable $100 Human Genome

  2. Illumina Sues BGI Again, Alleging New CoolMPS Chemistry Infringes SBS Patents

  3. Oxford Nanopore Licenses NuProbe Sample Prep Technology

  4. Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

  5. NeoGenomics Q4 Revenue Up 40 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.